(7R, 8S, 8′S, 7″S, 8″R)-abiesol A 4″-O-β-d-glucopyranoside, and it was named capselloside.
Capselloside (1): Brownish gum; [α]25D −34.0 (c = 0.05, MeOH); UV (MeOH) λmax (log ε) 280 (1.4), 228 (3.3), 214 (3.1) nm; IR (KBr) νmax 3261, 2946, 2816, 1638, 1489, 1261 cm−1; CD (MeOH) λmax (Δ ε) 291 (−), 280 (−) 257 (−) 230 (−) 223 (+); 1H (700 MHz) and 13C (175 MHz) NMR data, see Table 1; HR-FABMS (positive-ion mode) m/z: 723.2626 [M + Na]+ (calcd. for C36H44O14Na, 723.2629).
Compound 1 was obtained as a brownish gum. The molecular formula was established as C36H44O14using HR-FABMS, which showed a positive ion [M + Na]+ at m/z: 723.2626 (calcd. for C36H44O14Na, 723.2629, so the molecular formula was deduced to be C36H44O14.
The 1H-NMR spectrum of 1 revealed the presence of two 1,3,4-trisubstituted aromatic rings (δH 7.16 (d, J = 8.3 Hz, H-5′′), 7.15 (d, J = 8.2 Hz, H-5), 7.05 (d, J = 1.7 Hz, H-2), 7.01 (d, J = 1.7 Hz, H-2′′), 6.95 (dd, J = 8.2, 1.7 Hz, H-6), and 6.90 (dd, J = 8.2, 1.7 Hz, H-6″)), a 1,3,4,5-tetrasubstitued aromatic ring (δH 6.76 (s, H-6′), 6.78 (s, H-2′)), two oxygenated methines (δH 5.58 (d, J = 5.9 Hz, H-7) and 4.85 (m, H-7′′)), two oxygenated methylenes (δH 3.85 (m, H-9b), 3.78 (m, H-9a), and 3.88 (m, H-9′′a), 3.68 (dd, J = 10.9, 6.7 Hz, H-9b′′)), a methylene 2.96 ((dd, J = 13.5, 5.0 Hz, H-7′a), and 2.57 (dd, J = 13.3, 11.0 Hz, H-7′b)), three methines (δH 3.48 (m, H-8), 2.75 (sep, J = 6.5, 5.5 Hz, H-8′), and 2.38 (quin, J = 6.9 Hz, H-8″)), three methoxy groups (δH 3.88 (s, 3-OCH3), 3.87 (s, 5′-OCH3) and 3.84 (s, 3′′-OCH3)), and a glucopyanosyl unit (δH 4.91 (d, J = 7.3 Hz, H-1′′′), 3.69 (m, H-6′′′), 3.51 (m, H-2′′′), 3.41 (overlap, H-4′′′, 5′′′) and 3.39 (m, H-3′′′).
The 13C-NMR spectrum displayed 36 carbon signals, including 18 aromatic carbons δC 151.1 (C-3″), 147.9 (C-4′, 3′), 147.8 (C-3), 147.5 (C-4, 4″), 145.5 (C-5′), 139.7 (C-1″), 135.7 (C-1), 134.9 (C-1′), 119.7 (C-6″), 119.5 (C-6), 118.4 (C-6′), 118.2 (C-5″), 118.1 (C-5), 114.7 (C-2′), 111.5 (C-2″) and 111.3 (C-2), three oxygenated carbons δC 88.6 (C-7), 83.9 (C-7″), and 73.5 (C-9′), three methylene carbons δC 65.1 (C-9), 60.5 (C-9″), 33.9 (C-7′) and three methine carbons δC55.7 (C-8), 54.2 (C-8″), 44.0 (C-8′), and, three methoxy carbons (δC 56.9 and 56.8 (×2)), and glucose carbons δc 103.1 (C-1′′′), 78.5 (C-3′′′), 78.4 (C-5′′′), 75.1 (C-2′′′), 71.6 (C-4′′′), and 62.6 (C-6′′′) (Table 1).
Position | δC, Type | δH (J in Hz) |
---|---|---|
1 | 135.7, C | |
2 | 111.3, CH | 7.05, d (1.7) |
3 | 147.8, C | |
4 | 147.5, C | |
5 | 118.1, CH | 7.15, d (8.2) |
6 | 119.5, CH | 6.95, dd (8.2, 1.7) |
7 | 88.6, CH | 5.58, d (5.91) |
8 | 55.7, CH | 3.48, m |
9 | 65.1, CH2 | |
a | 3.78, m | |
b | 3.85, m | |
1′ | 134.9, C | |
2′ | 114.7, CH | 6.78, s |
3′ | 147.9, C | |
4′ | 147.9, C | |
5′ | 145.5, C | |
6′ | 118.4, CH | 6.76, s |
7′ | 33.9, CH2 | |
a | 2.96, dd (13.5, 5.0) | |
b | 2.57, dd (13.3, 11.0) | |
8′ | 44.0, CH | 2.75, sep (6.5, 5.5) |
9′ | 73.5, CH2 | |
a | 3.78, m | |
b | 4.05, dd (8.3, 6.6) | |
1″ | 139.7, C | |
2″ | 111.5, CH | 7.01, d (1.7) |
3″ | 151.1, C | |
4″ | 147.5, C | |
5″ | 118.2, CH | 7.16, d (8.3) |
6″ | 119.7, CH | 6.90, dd (8.2, 1.7) |
7″ | 83.9, CH | 4.85, overlap |
8″ | 54.2, CH | 2.38, quin (6.9) |
9″ | 60.5, CH2 | |
a | 3.88, m | |
b | 3.68, dd (10.9, 6.7) | |
Glc-1′′′ | 103.1, CH | 4.91, d (7.3) |
2′′′ | 75.1, CH | 3.51, m |
3′′′ | 78.5, CH | 3.39, m |
4′′′ | 71.6, CH | 3.41, m |
5′′′ | 78.4, CH | 3.41, m |
6′′′ | 62.6, CH | 3.69, overlap |
OCH3 (3″) | 56.9 | 3.84, s |
OCH3 (3) | 56.8 | 3.88, s |
OCH3 (5′) | 56.8 | 3.87, s |
Molecules2017, 22(6), 1023; doi:10.3390/molecules22061023
Abstract:
Capsella bursa-pastoris; Cruciferae; sesquilignan glycoside; anti-inflammatory